Select a medication above to begin.
Cefepime/ Taniborbactam
cefepime/ taniborbactam
Adult Dosing .
Dosage forms: INJ
Investigational New Drug (IND)
- [FDA approval denied, February 2024]
UTI, complicated
- [FDA approval denied]
- Info: cefepime binds to peptidoglycan, inhibiting cell wall synthesis; taniborbactam inhibits beta-lactamases, preventing beta-lactam degradation
Peds Dosing .
- Dosage forms: --
Investigational New Drug (IND)
- [FDA approval denied, February 2024]
- Info: not anticipated to be applicable to Peds population